Release Notes; Version 20180516
General Notes
The following files will be available as full release files within this version:
- Manufactured Product,
- Non-proprietary Therapeutic Product,
- Therapeutic Moiety,
- Manufactured Product, Non-proprietary Therapeutic Product, Therapeutic Product Relationship,
- Special Groupings,
- Coded Attribute, and
- Device Non-proprietary Therapeutic Product.
The 'Full" release contains one entry for every concept that has ever been released and new content added for that release. New content added for a specific release may at times include “Inactive” content.
The “Delta" release contains only those concepts that have been added or changed since the previous release. The type of changes would include; inactivated and changes to any description. Delta files will be provided in a future release.
The scope of this release includes most of the top 250 moieties plus additional content beyond the top 250.
The table below provides the number of concepts within each CCDD file for this release.
May 2018 CCDD Files | Number of Concepts | Types of Changes in this release |
|---|---|---|
| Therapeutic Moiety Full Release | 488 | 85 additions 1 status change |
| Non-proprietary Therapeutic Product Full Release | 1829 | 235 additions 1 concept with formal name change (see NTP specific comments below) 3 status change from Active to Inactive 1 status changes from Active to Deprec (deprecated), and 3 concepts to replace it (see below) 7 status date changes |
| Manufactured Product Full Release | 7021 | 534 additions Formal name changes made:
20 status changes from Active to Inactive 55 status date changes |
Manufactured Product, Non-proprietary Therapeutic Product, Therapeutic Product Relationship | 7021 | Includes concept additions and formal name changes as above |
| Device Non-proprietary Therapeutic Product | 3 | no change |
| Special Groupings | 1430 | 32 additions Includes concept additions and formal name changes as above |
| Coded Attributes | 7 | no change |
NTP Specific Comments
The following concept had a formal name change (with no change to the identifier)
ntp_code | ntp_formal_name May 2018 | ntp_formal_name April 2018 |
9006267 | sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection syringe | sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection 0.5 mL syringe |
The following concept was deprecated: estradiol 0.1 % transdermal gel, 9009350
and replaced by:
| 9012569 | estradiol 0.1 % transdermal gel 0.5 mg sachet |
| 9012568 | estradiol 0.1 % transdermal gel 0.25 mg sachet |
| 9012570 | estradiol 0.1 % transdermal gel 1 mg sachet |
Manufactured Product Specific Comments
The following table provides the MPs that have changed in the May release as a result of a NTP name change.
| May Release | April Release | ||
| 02212188 | IMITREX (sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection syringe) GLAXOSMITHKLINE INC | 02212188 | IMITREX (sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection 0.5 mL syringe) GLAXOSMITHKLINE INC |
| 02361698 | TARO-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection syringe) TARO PHARMACEUTICALS INC | 02361698 | TARO-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection 0.5 mL syringe) TARO PHARMACEUTICALS INC |
| 02424924 | DIVIGEL 0.25 MG PACK (estradiol 0.1 % transdermal gel 0.25 mg sachet) TEVA CANADA LIMITED | 02424924 | DIVIGEL 0.25 MG PACK (estradiol 0.1 % transdermal gel) TEVA CANADA LIMITED |
| 02424835 | DIVIGEL 0.5MG PACK (estradiol 0.1 % transdermal gel 0.5 mg sachet) TEVA CANADA LIMITED | 02424835 | DIVIGEL 0.5MG PACK (estradiol 0.1 % transdermal gel) TEVA CANADA LIMITED |
| 02424843 | DIVIGEL 1MG PACK (estradiol 0.1 % transdermal gel 1 mg sachet) TEVA CANADA LIMITED | 02424843 | DIVIGEL 1MG PACK (estradiol 0.1 % transdermal gel) TEVA CANADA LIMITED |
It is the intent of the CCDD formal names to always be unique. However, in this release there remains a few Manufactured Product concept formal names that did not generate uniquely following the CCDD Manufactured Product naming pattern as documented in the MP Formal Name Pattern section of the Editorial Guidelines. See below for an example:
02028174 | ACETAMINOPHEN, CAFFEINE & CODEINE (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) PHARMASCIENCE INC |
02025337 | ACETAMINOPHEN, CAFFEINE & CODEINE (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) PHARMASCIENCE INC |
This lack of unique formal names for the Manufactured Product will continue to be addressed via a change made to the Health Canada Drug Database over the course of the next couple of months.
Terminology Gateway Specific Comments
A link to the Release notes on this page has been added to the Gateway CCDD files. Users may use the "Change Logs" available when viewing each individual file on the Gateway. The change logs identify the additions and changes to a code or formal name only. If there has been a change to a status or status date, it will not appear in the change log at this time.
Questions, Concerns, Changes
Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]
Please note that to access InfoCentral, you must have an Infoway login. If you have any questions about any of our standards or products, please contact the Infodesk Desk at:
Toll Free #: 1-877-595-3417 or 416-595-3417
E-mail: [email protected]